Form 4: DSS, Inc. Reports Sale of Impact Biomedical Inc. Shares

DSS, Inc. reports the sale of 890,800 shares of Impact Biomedical Inc. common stock at a price of $0.9486 per share on April 4, 2025.

Summary

• DSS, Inc. filed a Form 4 with the SEC on April 7, 2025, reporting changes in beneficial ownership of Impact Biomedical Inc. stock.
• On April 4, 2025, DSS, Inc. sold 890,800 shares of common stock at $0.9486 per share.
• Following the transaction, DSS, Inc. directly owns 161,100 shares of Impact Biomedical Inc. common stock.
• DSS, Inc. also indirectly owns 1,178,882 shares through its wholly-owned subsidiary, DSS BioHealth Security, Inc.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of stock sale. The impact on the company depends on the reasons behind the sale and the overall market perception.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders or major shareholders of a publicly traded company buy or sell shares. This filing indicates a change in DSS, Inc.'s ownership stake in Impact Biomedical Inc.

Stakeholder Impact

• The sale of shares by a major shareholder like DSS, Inc. could potentially influence investor sentiment towards Impact Biomedical Inc.

Key Dates

Keywords

Form 4, beneficial ownership, Impact Biomedical Inc., DSS, Inc., stock sale, IBO